Immuron Stock Surges Friday: What's Driving the Action?
Immuron shares are surging Friday after it announced an exclusive deal with Calmino group AB to launch PROIBS gut health product in the U.S.
Immuron made a deal to sell a gut health product in the U.S., which made its stock price go up on Friday. When a company finds a partner to sell their product in a big new market, it shows people believe the company might grow.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.